Tonix Pharmaceuticals Holding Corp.
Stock Forecast, Prediction & Price Target
Tonix Pharmaceuticals Holding Corp. Financial Estimates
Tonix Pharmaceuticals Holding Corp. Revenue Estimates
Tonix Pharmaceuticals Holding Corp. EBITDA Estimates
Tonix Pharmaceuticals Holding Corp. Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $7.76M 0% | Avg: $17.78M Low: $15.73M High: $19.81M avg. 128.93% | Avg: $44.59M Low: $39.74M High: $49.42M avg. 150.74% | Avg: $379.69M Low: $338.43M High: $420.82M avg. 751.51% | Avg: $657.95M Low: $586.46M High: $729.23M avg. 73.28% |
Net Income
% change YoY
| $-92.21M N/A | $-115.00M -24.71% | $-116.65M -1.43% | Avg: $-91.08M Low: $-474.37M High: $-272.62M avg. 21.91% | Avg: $-77.81M Low: $-338.05M High: $-136.31M avg. 14.56% | Avg: $659.76M Low: $566.56M High: $752.68M avg. 947.84% | Avg: $41.06M Low: $35.26M High: $46.84M avg. -93.77% |
EBITDA
% change YoY
| $-92.31M N/A | $-112.09M -21.42% | $-114.08M -1.78% | Avg: $10.66M Low: $9.44M High: $11.89M avg. 109.35% | Avg: $26.75M Low: $23.84M High: $29.65M avg. 150.74% | Avg: $227.81M Low: $203.06M High: $252.49M avg. 751.51% | Avg: $394.77M Low: $351.87M High: $437.54M avg. 73.28% |
EPS
% change YoY
| -$51.2 N/A | -$20.11 60.72% | -$219.09 -989.45% | Avg: -$22.08 Low: -$27.84 High: -$16 avg. 89.92% | Avg: -$13.92 Low: -$19.84 High: -$8 avg. 36.95% | Avg: $38.72 Low: $33.25 High: $44.17 avg. 378.16% | Avg: $2.41 Low: $2.07 High: $2.75 avg. -93.77% |
Operating Expenses
% change YoY
| $92.31M N/A | $112.09M 21.42% | $121.40M 8.31% | Avg: $28.17M Low: $24.93M High: $31.39M avg. -76.79% | Avg: $70.64M Low: $62.96M High: $78.29M avg. 150.74% | Avg: $601.53M Low: $536.17M High: $666.70M avg. 751.51% | Avg: $1.04B Low: $929.11M High: $1.15B avg. 73.28% |
FAQ
What is Tonix Pharmaceuticals Holding Corp. stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 222.63% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is -474.37M, average is -91.08M and high is -272.62M.
What is Tonix Pharmaceuticals Holding Corp. stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 276.11% in 2025-2028.
We have gathered data from 2 analysts. Their low revenue estimate is $15.73M, average is $17.78M and high is $19.81M.
What is Tonix Pharmaceuticals Holding Corp. stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 102.81% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$27.84, average is -$22.08 and high is $-16.